Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

This EHA-ESMO Clinical Practice Guideline provides key recommendations for managing HIV-associated lymphomas.The guideline covers clinical, imaging and pathological diagnosis; staging and risk assessment; treatment and follow-up.The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe.Recommendations are based on available scientific data and the authors' collective expert opinion.

Authors

Institutions

Publication Details

Journal
HemaSphere
Published
2024-09-01
DOI
https://doi.org/10.1002/hem3.150
Citations
5
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.12

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

Éric Oksenhendler, Simon Collins, Silvia Montoto, Uta Brunnberg et al.
5 citations
HemaSphere
Lymphoma Diagnosis and Treatment
2.12
article

Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

Éric Oksenhendler, Simon Collins, Silvia Montoto, Uta Brunnberg, Philipp Schommers, Kate Cwynarski, Christian Buske, Marcus Hentrich, Christian Hoffmann, Mariana Bastos‐Oreiro, Marie José Kersten, Bastian von Tresckow, Alessandro Re, Chiara M. Cattaneo, Martin Dreyling, José‐Tomás Navarro, Mark Bower, Caroline Besson, Josep‐María Ribera, Kai Hübel, Igor Aurer, A. J. Davies, Alessia Dalla Pria
article en
5 citations

Abstract

This EHA-ESMO Clinical Practice Guideline provides key recommendations for managing HIV-associated lymphomas.The guideline covers clinical, imaging and pathological diagnosis; staging and risk assessment; treatment and follow-up.The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe.Recommendations are based on available scientific data and the authors' collective expert opinion.

HemaSphereVol. 8(9)
Goethe University Frankfurt (DE), Universitat Autònoma de Barcelona (ES), University College Hospital (GB), St Bartholomew's Hospital (GB), University Hospital Centre Zagreb (HR), Inserm (FR), University of Zagreb (HR), Université de Versailles Saint-Quentin-en-Yvelines (FR), Barts Health NHS Trust (GB), Université Paris-Saclay (FR), Southampton General Hospital (GB), University Hospital Southampton NHS Foundation Trust (GB), Hospital General Universitario Gregorio Marañón (ES), Josep Carreras Leukaemia Research Institute (ES), Northampton General Hospital NHS Trust (GB), Krankenhaus vom Roten Kreuz (DE), Assistance Publique – Hôpitaux de Paris (FR), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Centre de recherche en Epidémiologie et Santé des Populations (FR), Institut Català d'Oncologia (ES), Infektionsmedizinisches Centrum Hamburg (DE), École Nationale Supérieure d'Architecture de Versailles (FR), Essen University Hospital (DE), Institute of Clinical Cancer Research (DE), University Hospital Frankfurt (DE), Chelsea and Westminster Hospital (GB), Hôpital Saint-Louis (FR), Amsterdam University Medical Centers (NL), University Hospital Cologne (DE), University Hospital Ulm (DE), Centre Hospitalier de Versailles (FR), West German Heart and Vascular Center Essen (DE), University College London (GB), University of Duisburg-Essen (DE), Ludwig-Maximilians-Universität München (DE)
Cancer Research Institute, Lymphoma Research Foundation, Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Celgene, CSL Behring, National Cancer Research Institute, Regeneron Pharmaceuticals, ViiV Healthcare, Jazz Pharmaceuticals, Les Laboratories Pierre Fabre, Atara Biotherapeutics, BeiGene, Recordati Rare Diseases, Incyte, Celltrion, European Society for Medical Oncology, Servier, Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung, Swedish Orphan Biovitrum, MorphoSys, Italfarmaco, EUSA Pharma, Lilly Deutschland, Kite Pharma, Cilag
Good health and well-being
Openalex Percentile: Top 13%
Lymphoma Diagnosis and Treatment
2.12
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.